hybridization oligonucleotide microarray Search Results


oligonucleotide microarray hybridization  (Genisphere llc)
90
Genisphere llc oligonucleotide microarray hybridization
Oligonucleotide Microarray Hybridization, supplied by Genisphere llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligonucleotide microarray hybridization/product/Genisphere llc
Average 90 stars, based on 1 article reviews
oligonucleotide microarray hybridization - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
oligonucleotide microarray hybridization  (Veracyte Inc)
90
Veracyte Inc oligonucleotide microarray hybridization
Association of immune marker signatures with PSA response and OS. (A) The correlations between the 24 non-redundant (ie, those without high Spearman correlations among each other) set of evaluated tumor immune microenvironment gene expression signatures (ρ is shown), (B) OS of the group with tumor immune gene expression signature analysis is not significantly different from the overall cohort of Lu-PSMA therapy treated patients at our institution and (C) the <t>cDNA</t> yield from RNA extracted from tumor samples, best PSA response and relative expression signature level (z-scores, higher values indicate higher signature) of immune-related gene signatures are shown correspondingly to identify patterns of signatures with regard to PSA response. Patients with higher PD-L2 signature (above the median) have longer OS time (D) and greater PSA responses (E). Lu-PSMA, [ 177 Lu]Lutetium-PSMA-617; mo., months; OS, overall survival; PD-L1, programmed death-ligand 1; PSA, prostate-specific antigen.
Oligonucleotide Microarray Hybridization, supplied by Veracyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligonucleotide microarray hybridization/product/Veracyte Inc
Average 90 stars, based on 1 article reviews
oligonucleotide microarray hybridization - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
oligonucleotide rat microarray hybridization a rattus norvegicus wistar strain 5000 oligo library set  (Operon Biotech)
90
Operon Biotech oligonucleotide rat microarray hybridization a rattus norvegicus wistar strain 5000 oligo library set
Association of immune marker signatures with PSA response and OS. (A) The correlations between the 24 non-redundant (ie, those without high Spearman correlations among each other) set of evaluated tumor immune microenvironment gene expression signatures (ρ is shown), (B) OS of the group with tumor immune gene expression signature analysis is not significantly different from the overall cohort of Lu-PSMA therapy treated patients at our institution and (C) the <t>cDNA</t> yield from RNA extracted from tumor samples, best PSA response and relative expression signature level (z-scores, higher values indicate higher signature) of immune-related gene signatures are shown correspondingly to identify patterns of signatures with regard to PSA response. Patients with higher PD-L2 signature (above the median) have longer OS time (D) and greater PSA responses (E). Lu-PSMA, [ 177 Lu]Lutetium-PSMA-617; mo., months; OS, overall survival; PD-L1, programmed death-ligand 1; PSA, prostate-specific antigen.
Oligonucleotide Rat Microarray Hybridization A Rattus Norvegicus Wistar Strain 5000 Oligo Library Set, supplied by Operon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligonucleotide rat microarray hybridization a rattus norvegicus wistar strain 5000 oligo library set/product/Operon Biotech
Average 90 stars, based on 1 article reviews
oligonucleotide rat microarray hybridization a rattus norvegicus wistar strain 5000 oligo library set - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
oligonucleotide microarray comparative genomic hybridization  (Eli Lilly)
90
Eli Lilly oligonucleotide microarray comparative genomic hybridization
Association of immune marker signatures with PSA response and OS. (A) The correlations between the 24 non-redundant (ie, those without high Spearman correlations among each other) set of evaluated tumor immune microenvironment gene expression signatures (ρ is shown), (B) OS of the group with tumor immune gene expression signature analysis is not significantly different from the overall cohort of Lu-PSMA therapy treated patients at our institution and (C) the <t>cDNA</t> yield from RNA extracted from tumor samples, best PSA response and relative expression signature level (z-scores, higher values indicate higher signature) of immune-related gene signatures are shown correspondingly to identify patterns of signatures with regard to PSA response. Patients with higher PD-L2 signature (above the median) have longer OS time (D) and greater PSA responses (E). Lu-PSMA, [ 177 Lu]Lutetium-PSMA-617; mo., months; OS, overall survival; PD-L1, programmed death-ligand 1; PSA, prostate-specific antigen.
Oligonucleotide Microarray Comparative Genomic Hybridization, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligonucleotide microarray comparative genomic hybridization/product/Eli Lilly
Average 90 stars, based on 1 article reviews
oligonucleotide microarray comparative genomic hybridization - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Association of immune marker signatures with PSA response and OS. (A) The correlations between the 24 non-redundant (ie, those without high Spearman correlations among each other) set of evaluated tumor immune microenvironment gene expression signatures (ρ is shown), (B) OS of the group with tumor immune gene expression signature analysis is not significantly different from the overall cohort of Lu-PSMA therapy treated patients at our institution and (C) the cDNA yield from RNA extracted from tumor samples, best PSA response and relative expression signature level (z-scores, higher values indicate higher signature) of immune-related gene signatures are shown correspondingly to identify patterns of signatures with regard to PSA response. Patients with higher PD-L2 signature (above the median) have longer OS time (D) and greater PSA responses (E). Lu-PSMA, [ 177 Lu]Lutetium-PSMA-617; mo., months; OS, overall survival; PD-L1, programmed death-ligand 1; PSA, prostate-specific antigen.

Journal: Journal for Immunotherapy of Cancer

Article Title: Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy

doi: 10.1136/jitc-2023-007354

Figure Lengend Snippet: Association of immune marker signatures with PSA response and OS. (A) The correlations between the 24 non-redundant (ie, those without high Spearman correlations among each other) set of evaluated tumor immune microenvironment gene expression signatures (ρ is shown), (B) OS of the group with tumor immune gene expression signature analysis is not significantly different from the overall cohort of Lu-PSMA therapy treated patients at our institution and (C) the cDNA yield from RNA extracted from tumor samples, best PSA response and relative expression signature level (z-scores, higher values indicate higher signature) of immune-related gene signatures are shown correspondingly to identify patterns of signatures with regard to PSA response. Patients with higher PD-L2 signature (above the median) have longer OS time (D) and greater PSA responses (E). Lu-PSMA, [ 177 Lu]Lutetium-PSMA-617; mo., months; OS, overall survival; PD-L1, programmed death-ligand 1; PSA, prostate-specific antigen.

Article Snippet: RNA was extracted from formalin-fixed paraffin embedded tumor tissue and underwent cDNA amplification, oligonucleotide microarray hybridization and microarray quality control in a Clinical Laboratory Improvement Amendments-certified laboratory (Veracyte, San Diego, California, USA) as previously described.

Techniques: Marker, Gene Expression, Expressing